Opko Health OPK
NASDAQ OPK
$1.72 +0.03 (+1.82%)
As of: Sep 22, 2026 · 11:36 AM EDT

Opko Health (OPK) Non-Current Assets (2010 - 2026)

Opko Health's (OPK) quarterly Non-Current Assets came in at $1.3 billion in Q2 2026, down 4.35% on a YoY basis from $1.4 billion in Q2 2025, and up 0.59% quarter-over-quarter from $1.3 billion in Q1 2026.

Analysis

Opko Health (OPK) Non-Current Assets (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported Non-Current Assets for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Assets fell 4.35% year-over-year to $1.3 billion; the trailing twelve-month figure through Jun 2026 stood at $5.4 billion (down 9.69% YoY), and the FY2025 full-year result was $1.4 billion, down 12.23% from the prior year.
  • Non-Current Assets climbed to $1.3 billion in Q2 2026 per OPK's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.9 billion in Q2 2022 and bottomed at $1.3 billion in Q1 2026.
  • Historically, Non-Current Assets has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2024.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Assets decreased 19.15% in 2022, then gained 13.55% in 2023.
  • Over 5 years, Non-Current Assets stood at $1.8 billion in 2022, then declined by 3.98% to $1.7 billion in 2023, then retreated by 9.64% to $1.5 billion in 2024, then decreased by 12.23% to $1.4 billion in 2025, then dropped by 1.54% to $1.3 billion in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $1.3 billion, $1.3 billion, and $1.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 141.29 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 101.45 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 94.68 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 159.77 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 59.06 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 113.37 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 294.93 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 1.96 Bn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn 1.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.33 Bn
Mar 31, 2026 1.32 Bn
Dec 31, 2025 1.35 Bn
Sep 30, 2025 1.37 Bn
Jun 30, 2025 1.39 Bn
Mar 31, 2025 1.39 Bn
Dec 31, 2024 1.54 Bn
Sep 30, 2024 1.63 Bn
Jun 30, 2024 1.62 Bn
Mar 31, 2024 1.58 Bn
Dec 31, 2023 1.70 Bn
Sep 30, 2023 1.70 Bn
Jun 30, 2023 1.73 Bn
Mar 31, 2023 1.76 Bn
Dec 31, 2022 1.77 Bn
Sep 30, 2022 1.81 Bn
Jun 30, 2022 1.87 Bn
Mar 31, 2022 1.55 Bn
Dec 31, 2021 1.58 Bn
Sep 30, 2021 1.86 Bn
API Access

Opko Health Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=OPK&period=max&api_key=YOUR_API_KEY